Details for New Drug Application (NDA): 019668

✉ Email this page to a colleague

NDA 019668 describes CARDURA, which is a drug marketed by Viatris and is included in two NDAs. It is available from three suppliers. Additional details are available on the CARDURA profile page.

The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.

Summary for 019668

Tradename:	CARDURA
Applicant:	Viatris
Ingredient:	doxazosin mesylate
Patents:	0

Pharmacology for NDA: 019668

Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for 019668

Adrenergic alpha-1 Receptor Antagonists
Antihypertensive Agents

Suppliers and Packaging for NDA: 019668

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CARDURA	doxazosin mesylate	TABLET;ORAL	019668	NDA	ROERIG	0049-2410	0049-2410-10	100 TABLET in 1 BOTTLE (0049-2410-10)
CARDURA	doxazosin mesylate	TABLET;ORAL	019668	NDA	ROERIG	0049-2512	0049-2512-10	100 TABLET in 1 BOTTLE (0049-2512-10)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 1MG BASE
Approval Date:	Nov 2, 1990	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 2MG BASE
Approval Date:	Nov 2, 1990	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 4MG BASE
Approval Date:	Nov 2, 1990	TE:	AB	RLD:	Yes

Expired US Patents for NDA 019668

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-001	Nov 2, 1990	⤷ Subscribe	⤷ Subscribe
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-004	Nov 2, 1990	⤷ Subscribe	⤷ Subscribe
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-003	Nov 2, 1990	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.